Pulsar Helium (AIM: PLSR) has had a lively few months, and anyone watching the chart will have noticed it. The share price jumped from about 22 pence on 17th September
Greenland: Why Primary Helium Explorer Pulsar Helium Is Uniquely Positioned.
International headlines this week spotlight intensifying geopolitical debate over Greenland’s future, spurred by renewed calls from U.S. policymakers for America to acquire influence and possible control of the island’s territory
Pulsar Helium Inc. (AIM: PLSR, TSXV: PLSR, OTCQB: PSRHF) Additional High-Pressure Gas Encounter Jetstream 5
PULSAR HELIUM REPORTS ADDITIONAL HIGH-PRESSURE GAS ENCOUNTER AT JETSTREAM #5 AND OUTLINES UPCOMING TESTING PROGRAM
Global Stock Market Rally Loses Momentum as European Shares Fall
The new year rally in global stock markets appears to have lost momentum, with investors turning more cautious amid fresh corporate and macroeconomic concerns.
Genflow Biosciences PLC (LON: GENF) A Review of an Exciting 2025
Genflow Biosciences PLC (LON: GENF) said it made solid operational progress during 2025, advancing multiple programmes across aging, metabolic disease and gene therapy, while laying the groundwork for a more
Pulsar Helium Inc. (AIM: PLSR, TSXV: PLSR, OTCQB: PSRHF) Acquisition of Michigan Helium Exploration Assets
PULSAR HELIUM ANNOUNCES ACQUISITION OF MICHIGAN HELIUM EXPLORATION ASSETS-FOCUSED GAS EXPLORATION COMPANY
Pulsar Helium: A Retail Investor’s Look at a Fast-Moving Early Explorer
Pulsar Helium (AIM: PLSR) has had a lively few months, and anyone watching the chart will have noticed it. The share price jumped from about 22 pence on 17th September
Trader’s Café With Zak Mir: The Week In Small Caps, Sunday 21st December 2025
Self-Proclaimed Vigilantes Continued
Pulsar Helium Inc. (AIM: PLSR, TSXV: PLSR, OTCQB: PSRHF) Closes Major Minnesota Land Position and TVR
PULSAR HELIUM CLOSES MAJOR MINNESOTA LAND POSITION TO THE WEST OF TOPAZ PROJECT AND TVR
Pulsar Helium Inc. updates on share-based compensation and AIM issuance
Pulsar Helium Inc. (AIM: PLSR, TSXV: PLSR, OTCQB: PSRHF), a primary helium exploration and development company, announces that on December 16, 2025, the Board of Directors (the “Board”) awarded security
Genflow Biosciences Plc (LON: GENF) Completion of Dosing Phase of Canine Gene Therapy
Genflow Completes Dosing Phase of Canine Gene Therapy Trial No Adverse Events Reported During Administration
Genflow Biosciences Plc (LON: GENF) to pitch longevity gene therapy at JPM 2026
Genflow to Attend the 44th Annual J.P. Morgan Healthcare Conference